WHO: Craig Shimasaki, Ph.D., MBA is president & CEO of Moleculera Labs, an autoimmune neurobiology company. He is a scientist and serial entrepreneur with over 32 years of biotechnology industry experience. In addition to co-founding three companies, he is the author and editor of two books – “The Business of Bioscience: What Goes into Making a Biotechnology Product” and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.” He is an adjunct professor at the University of Oklahoma, Price School of Business, where he teaches biotechnology entrepreneurship.
WHAT: The business decisions that biotech entrepreneurs make in the beginning may seem like the right thing to do at the time. However, these early decisions may not be the best foundation for long-term success.
In this free event, Dr. Shimasaki will share his experiences as an entrepreneur in the biotech industry. He will discuss the seven most common startup mistakes that life sciences leaders make and provide insight on how to recognize and repair these mistakes before time and capital run out.
Complimentary breakfast will be served.
WHEN: Wednesday, Sept. 14, 2016
8 a.m. – 10 a.m. ET
WHERE: Catalyst restaurant
300 Technology Square
Cambridge, MA 02139
REGISTER: RSVP here; space is limited.
April 6, 2020
Dublin, CA — April 6, 2020 — TriNet, a leading provider of comprehensive human resources, is providing its more than 18,000* small and medium size business (SMB) customers with a one-stop resource for how major health insurance carriers are adapting their offerings during the COVID-19 pandemic. These adaptions include such vital services as waived copays, cost-sharing, lab testing and telemedicine.
March 30, 2020
With COVID-19 delivering the U.S. economy a hard hit, along with employees at risk of losing their health coverage, small and medium size businesses need to understand the range of health coverage offerings available to them.